{
  "id": "ngn-sa-2026-batch300-112-1771348413350",
  "version": 1,
  "questionType": "standalone-priorityAction",
  "difficulty": 4,
  "seed": "BATCH-300-112-1771348413350",
  "topic": "Hyperthyroidism/Grave's Disease",
  "cjmmStep": "Take Actions",
  "question": "A nurse in the emergency department is preparing a 38-year-old client for discharge. The client was diagnosed with Grave's disease and has new prescriptions for methimazole and propranolol. The client is hemodynamically stable and has a follow-up appointment with an endocrinologist in one week. Which instruction is the **priority** for the nurse to provide?",
  "options": [
    {
      "id": "opt_D",
      "text": "Increase your caloric intake to compensate for the increased metabolic rate."
    },
    {
      "id": "opt_A",
      "text": "Report any sudden onset of a sore throat or fever immediately."
    },
    {
      "id": "opt_B",
      "text": "Check your pulse before taking propranolol and hold the dose if it is below 60 beats per minute."
    },
    {
      "id": "opt_C",
      "text": "It may take several weeks for the methimazole to fully control your symptoms."
    },
    {
      "id": "opt_E",
      "text": "Monitor your weight weekly and expect a gradual increase as the medication becomes effective."
    }
  ],
  "correctAnswer": [
    "opt_A"
  ],
  "answerBreakdown": {
    "correctRationale": {
      "optionId": "opt_A",
      "explanation": "This is the priority instruction. Methimazole, an antithyroid medication, carries a risk of agranulocytosis, a potentially life-threatening condition characterized by a severe reduction in white blood cells (specifically neutrophils). This immunosuppression significantly increases the risk of opportunistic infections. A sore throat and fever are early indicators of infection. Prompt reporting and a complete blood count (CBC) are crucial for early detection and intervention with granulocyte colony-stimulating factor (G-CSF) or antibiotics to prevent sepsis and potentially fatal outcomes. The onset of agranulocytosis is typically within the first 3 months of therapy.",
      "pathophysiology": "Methimazole inhibits the enzyme thyroid peroxidase, which is essential for the synthesis of thyroid hormones. While effective in reducing thyroid hormone production, methimazole can, in rare cases, cause an idiosyncratic reaction leading to agranulocytosis. The exact mechanism is not fully understood, but it is believed to involve immune-mediated destruction or suppression of granulocyte precursors in the bone marrow. This results in a profound neutropenia, leaving the individual highly susceptible to bacterial and fungal infections."
    },
    "distractorRationale": [
      {
        "optionId": "opt_B",
        "explanation": "While monitoring pulse rate before propranolol administration is important to prevent bradycardia, it is not the priority instruction. Propranolol is a beta-blocker used to manage the symptomatic effects of hyperthyroidism (e.g., tachycardia, tremors). Although bradycardia is a concern, the risk of a life-threatening infection from untreated agranulocytosis is a more immediate and critical threat. The client should be instructed to monitor their pulse, but this is secondary to recognizing signs of infection.",
        "pathophysiology": "Propranolol blocks beta-adrenergic receptors, reducing the effects of excessive thyroid hormones on the cardiovascular system. This leads to a decrease in heart rate and blood pressure. However, it does not address the underlying cause of hyperthyroidism or the potential for agranulocytosis.",
        "clinicalPearl": "Propranolol is used for symptomatic relief in hyperthyroidism but does not treat the underlying cause. It is important to assess for contraindications such as asthma or COPD before administration."
      },
      {
        "optionId": "opt_C",
        "explanation": "While it is important to educate the client that methimazole takes several weeks to fully control hyperthyroid symptoms, this is a therapeutic communication point and not a critical safety instruction. Managing expectations is important for adherence, but recognizing and reporting signs of a potentially fatal adverse effect takes precedence.",
        "pathophysiology": "Methimazole gradually reduces thyroid hormone levels by inhibiting their synthesis. It does not affect pre-formed thyroid hormones, which is why it takes time to see the full therapeutic effect.",
        "clinicalPearl": "Educate patients that it may take 4-8 weeks to see the full effects of methimazole. Regular monitoring of thyroid function tests is essential during this period."
      },
      {
        "optionId": "opt_D",
        "explanation": "Clients with hyperthyroidism often require increased caloric intake due to their hypermetabolic state. However, this is a general dietary guideline and not an immediate safety concern related to the medication regimen. Medication safety is a higher priority than dietary management at discharge.",
        "pathophysiology": "Hyperthyroidism increases the basal metabolic rate, leading to increased energy expenditure and weight loss. Clients often require a higher caloric intake to maintain their weight and prevent malnutrition.",
        "clinicalPearl": "Encourage small, frequent meals and snacks to meet the increased caloric needs of hyperthyroid patients."
      },
      {
        "optionId": "opt_E",
        "explanation": "Monitoring weight is important to assess the effectiveness of methimazole treatment, as weight gain often indicates that the hyperthyroid state is being controlled. However, this is part of ongoing disease management and not an urgent safety priority compared to the need to recognize and report signs of agranulocytosis.",
        "pathophysiology": "As thyroid hormone levels normalize with methimazole treatment, the metabolic rate decreases, leading to weight gain. This is a sign that the medication is working effectively.",
        "clinicalPearl": "Weight gain is a common and expected side effect of methimazole treatment, indicating that the hyperthyroid state is being controlled. Monitor weight regularly and adjust caloric intake as needed."
      }
    ]
  },
  "sbar": {
    "situation": "0800: A 38-year-old client with Grave's disease is being discharged from the emergency department.",
    "background": "The client is hemodynamically stable and has new prescriptions for methimazole 5mg PO daily and propranolol 20mg PO BID. They have a follow-up appointment with an endocrinologist in one week.",
    "assessment": "The client requires discharge instructions regarding their new medications, specifically regarding potential adverse effects.",
    "recommendation": "Determine the priority instruction to provide to the client before discharge, emphasizing the importance of reporting signs of infection immediately."
  },
  "clinicalPearl": "Agranulocytosis is a rare but serious side effect of methimazole. Early recognition of signs and symptoms, such as sore throat and fever, is crucial for prompt intervention and prevention of life-threatening complications. Instruct patients to report these symptoms immediately and obtain a CBC.",
  "sentinelStatus": "healed_v2026_v8"
}